Thematic Take is a new product in our portfolio, exploring the impact of a specific technology or macro theme across sectors every month. It is published as a supplement in our digital industry magazines, and as a standalone monthly magazine.

We define a theme as any issue that keeps business leaders awake at night. We help company leaders navigate disruption by tracking these themes across all companies in all sectors.

Position yourself as a leader in the key themes impacting industry by sponsoring our Thematic Take supplements or magazines.

Read our previous supplement: Internet of Things in pharma

Upcoming Thematic Take supplements
April 2024: Blockchain
June 2024: ESG
August 2024: Cybersecurity
October 2024: AI
December 2024: Yearbook

For more information about this and other sponsorship opportunities contact Tom McCormick: tom.mccormick@nridigital.com

Go to article: Home | Biotechs surf obesity drug wave to go beyond GLP-1RAsGo to article: Editor's letterGo to article: ContentsGo to article: Mimotopes Company InsightGo to article: MimotopesGo to article: BriefingGo to article: News in NumbersGo to article: Latest NewsGo to article: Latest DealsGo to article: Project UpdatesGo to article: Trends & InsightGo to article: Bio Image SystemsGo to article: phasetwoGo to article: In DepthGo to article: Biotechs surf obesity drug wave to go beyond GLP-1RAsGo to article: The opioid crisis: Different delivery systems tackle treatment needs Go to article: Pharma readies for climate disasters amidst supply chain concernsGo to article: CRISPR pipeline accelerates after milestone Casgevy approvalGo to article: The future of cell and gene therapy manufacturingGo to article: Amgen showcases exciting potential in the obesity space at JPM24 Go to article: Q&A: Regulatory reform necessary to improve obesity drug accessGo to article: Novo to buy Catalent: The backlash beginsGo to article: Sponsored SupplementsGo to article: BEA TechnologiesGo to article: ListingsGo to article: EventsGo to article: Innovation RankingsGo to article: Buyer's GuidesGo to article: Next issue